Skip to content

The Effect of Topical Sesame Oil on Severity of Pain in Patients with Limb Trauma

Assessing the Effect of Topical Sesame Oil on Severity of Pain in Patients with Limb Trauma

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180701040297N2
Enrollment
120
Registered
2019-03-25
Start date
2019-04-09
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients are traumatized.

Interventions

Intervention 1: Intervention group: After washing the area with normal saline, sesame oil (produced by Farabi Pharmaceutical Company) is poured on the area and then a circular massage is given with fi

Sponsors

Research and Technology Deputy of Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: the patients 18-60 years non-penetrating trauma of the upper or lower extremities occurrence of trauma between one to six hours prior to referral pain score 3-6 on visual analogue scale full consciousness

Exclusion criteria

Exclusion criteria: The presence of fractures in the injured limb The presence of bleeding at the site of the trauma dislocation of the injured limb amputation of the injured limb The presence of foreign body at the site of the trauma The presence of neurological damage in trauma location The presence of fever history of sensitivity or allergy to sesame

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: The pain is totally evaluated 7 times; before the intervention on the first day and 30 minutes after each intervention for 3 days(Twice a day). Method of measurement: The Visual Analogue Scale is used to measure the severity of pain that includes a continuous line with two initial and end points of zero to 10; Zero means no pain and 10 means the maximum pain intensity.

Secondary

MeasureTime frame
The amount of analgesic received during the intervention. Timepoint: At the end of the study. Method of measurement: Patient's document.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Kafash Mohammadjani

Guilan University of Medical Sciences

M.kafash.1359@gmail.com+98 13 3355 5056

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026